Pubblicazioni

The Profile of the Italian Centers for Cognitive Disorders and Dementia in the Context of New Drugs in Alzheimer's Disease

2024 - JOURNAL OF ALZHEIMER'S DISEASE

Giaquinto, Francesco; Lorenzini, Patrizia; Salvi, Emanuela; Carnevale, Giulia; Vaccaro, Roberta; Matascioli, Fabio; Corbo, Massimo; Locuratolo, Nicoletta; Vanacore, Nicola; Bacigalupo, Ilaria

Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination

2024 - FRONTIERS IN IMMUNOLOGY

OrrÃ¹, Valeria; Serra, Valentina; Marongiu, Michele; Lai, Sandra; Lodde, Valeria; Zoledziewska, Magdalena; Steri, Maristella; Loizedda, Annalisa; Lobina, Monia; Piras, Maria Grazia; Virdis, Francesca; Delogu, Giuseppe; Marini, Maria Giuseppina; Mingoia, Maura; Floris, Matteo; Masala, Marco; Castelli, M Paola; Mostallino, Rafaela; Frau, Jessica; Lorefice, Lorena; Farina, Gabriele; Fronza, Marzia; Carmagnini, Daniele; Carta, Elisa; Pilotto, Silvy; Chessa, Paola; Devoto, Marcella; Castiglia, Paolo; Solla, Paolo; Zarbo, Roberto Ignazio; Idda, Maria Laura; Pitzalis, Maristella; Cocco, Eleonora; Fiorillo, Edoardo; Cucca, Francesco

Targeting neuroinflammation to alleviate chronic olfactory dysfunction in Long COVID: a role for investigating disease-modifying therapy (DMT)?

2023 - LIFE

Di Stadio, Arianna; Bernitsas, Evanthia; La Mantia, Ignazio; Brenner, Michael J.; Ralli, Massimo; Angelo Vaira, Luigi; Colizza, Andrea; Cavaliere, Carlo; Laudani, Matteo; Frohman, Teresa; DE VINCENTIIS, Marco; Frohman, Elliot M.; Altieri, Marta

Drugs used in the treatment of multiple sclerosis during COVID-19 pandemic: a critical viewpoint

2021 - CURRENT NEUROPHARMACOLOGY

Alborghetti, Marika; Bellucci, Gianmarco; Gentile, Antonietta; Calderoni, Chiara; Nicoletti, Ferdinando; Capra, Ruggero; Salvetti, Marco; Centonze, Diego

Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients

2021 - FRONTIERS IN IMMUNOLOGY

Pitzalis, M.; Idda, M. L.; Lodde, V.; Loizedda, A.; Lobina, M.; Zoledziewska, M.; Virdis, F.; Delogu, G.; Pirinu, F.; Marini, M. G.; Mingoia, M.; Frau, J.; Lorefice, L.; Fronza, M.; Carmagnini, D.; Carta, E.; Orru, V.; Uzzau, S.; Solla, P.; Loi, F.; Devoto, M.; Steri, M.; Fiorillo, E.; Floris, M.; Zarbo, I. R.; Cocco, E.; Cucca, F.

Efficacy of alemtuzumab over 6 years in relapsingâremitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies

2020 - MULTIPLE SCLEROSIS

Van Wijmeersch, B.; Singer, B. A.; Boster, A.; Broadley, S.; Fernandez, O.; Freedman, M. S.; Izquierdo, G.; Lycke, J.; Pozzilli, C.; Sharrack, B.; Steingo, B.; Wiendl, H.; Wray, S.; Ziemssen, T.; Chung, L.; Margolin, D. H.; Thangavelu, K.; Vermersch, P.

Overview of magnetic resonance imaging for management of relapsing-remitting multiple sclerosis in everyday practice

2015 - EUROPEAN JOURNAL OF NEUROLOGY

Oreja-Guevara, C.; Pozzilli, C

Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations

2015 - EUROPEAN JOURNAL OF NEUROLOGY

Gallo, P.; Van Wijmeersch, B.; Pozzilli, C